Delivery Order SPE2DB22D3004-SPE2DB25FQ83A
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 unit/mL syringes valued at $2,311.38. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HAVRIX 1,440 Unit/ML Syringe vaccines valued at $1,339.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for completion by August 7, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,440 units of HAVRIX 1,440 Unit/mL syringes valued at $1,931.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a $33,589.80 delivery order to AmerisourceBergen Drug Corp for 1,440 units per milliliter of HAVRIX vaccine in syringe form. This competitively awarded, firm fixed price contract was executed on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified suppliers. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 Unit/mL syringe on August 26, 2025, with a ceiling value of $2,017.25 and an ultimate completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract represents a single transaction for the hepatitis A vaccine product, which will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,508.18 to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine in syringe form. This competitively awarded, firm fixed-price delivery order was finalized on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $2,547.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for 1,440 units/ml of Havrix vaccine in syringes. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-competitive, non-set-aside delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,666.37 firm fixed price delivery order for 1,440 units of HAVRIX 1,440 Unit/mL syringe on April 18, 2025, with ultimate completion scheduled for April 21, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania headquarters. HAVRIX is a hepatitis A vaccine commonly utilized by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...